175 related articles for article (PubMed ID: 18655532)
1. 21-hydroxylase deficiency transiently mimicking combined 21- and 11beta-hydroxylase deficiency.
Tonetto-Fernandes V; Lemos-Marini SH; De Mello MP; Ribeiro-Neto LM; Kater CE
J Pediatr Endocrinol Metab; 2008 May; 21(5):487-94. PubMed ID: 18655532
[TBL] [Abstract][Full Text] [Related]
2. Serum 21-Deoxycortisol, 17-Hydroxyprogesterone, and 11-deoxycortisol in classic congenital adrenal hyperplasia: clinical and hormonal correlations and identification of patients with 11beta-hydroxylase deficiency among a large group with alleged 21-hydroxylase deficiency.
Tonetto-Fernandes V; Lemos-Marini SH; Kuperman H; Ribeiro-Neto LM; Verreschi IT; Kater CE
J Clin Endocrinol Metab; 2006 Jun; 91(6):2179-84. PubMed ID: 16551734
[TBL] [Abstract][Full Text] [Related]
3. Superior discriminating value of ACTH-stimulated serum 21-deoxycortisol in identifying heterozygote carriers for 21-hydroxylase deficiency.
Costa-Barbosa FA; Tonetto-Fernandes VF; Carvalho VM; Nakamura OH; Moura V; Bachega TA; Vieira JG; Kater CE
Clin Endocrinol (Oxf); 2010 Dec; 73(6):700-6. PubMed ID: 20846292
[TBL] [Abstract][Full Text] [Related]
4. Reassessment of predictive values of ACTH-stimulated serum 21-deoxycortisol and 17-hydroxyprogesterone to identify CYP21A2 heterozygote carriers and nonclassic subjects.
Costa-Barbosa FA; Carvalho VM; Oliveira KC; Vieira JGH; Kater CE
Clin Endocrinol (Oxf); 2021 Oct; 95(4):677-685. PubMed ID: 34231242
[TBL] [Abstract][Full Text] [Related]
5. Clinical and Hormonal Profiles Correlate With Molecular Characteristics in Patients With 11β-Hydroxylase Deficiency.
Yildiz M; Isik E; Abali ZY; Keskin M; Ozbek MN; Bas F; Ucakturk SA; Buyukinan M; Onal H; Kara C; Storbeck KH; Darendeliler F; Cayir A; Unal E; Anik A; Demirbilek H; Cetin T; Dursun F; Catli G; Turan S; Falhammar H; Baris T; Yaman A; Haklar G; Bereket A; Guran T
J Clin Endocrinol Metab; 2021 Aug; 106(9):e3714-e3724. PubMed ID: 33830237
[TBL] [Abstract][Full Text] [Related]
6. Expanding genetic spectrum and discriminatory role of steroid profiling by LC-MS/MS in 11β-hydroxylase deficiency.
Karlekar MP; Sarathi V; Lila A; Rai K; Arya S; Bhandare VV; Atluri S; Patil V; Ramteke-Jadhav S; Shah NS; Kunwar A; Bandgar T
Clin Endocrinol (Oxf); 2021 Apr; 94(4):533-543. PubMed ID: 33275286
[TBL] [Abstract][Full Text] [Related]
7. Serum 21-Deoxycortisol for Diagnosis of Nonclassic Congenital Adrenal Hyperplasia in Women With Androgen Excess.
Ng JL; Lim EM; Zhang R; Beilby JP; Watts GF; Brown SJ; Stuckey BGA
J Clin Endocrinol Metab; 2023 Nov; 108(12):e1560-e1570. PubMed ID: 37358001
[TBL] [Abstract][Full Text] [Related]
8. Congenital adrenal hyperplasia caused by compound heterozygosity of two novel CYP11B1 gene variants.
Fylaktou I; Smyrnaki P; Sertedaki A; Dracopoulou M; Kanaka-Gantenbein C
Hormones (Athens); 2022 Mar; 21(1):155-161. PubMed ID: 34697763
[TBL] [Abstract][Full Text] [Related]
9. Testicular tumors in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency show functional features of adrenocortical tissue.
Claahsen-van der Grinten HL; Otten BJ; Sweep FC; Span PN; Ross HA; Meuleman EJ; Hermus AR
J Clin Endocrinol Metab; 2007 Sep; 92(9):3674-80. PubMed ID: 17595257
[TBL] [Abstract][Full Text] [Related]
10. Typical characteristics of children with congenital adrenal hyperplasia due to 11β-hydroxylase deficiency: a single-centre experience and review of the literature.
Breil T; Yakovenko V; Inta I; Choukair D; Klose D; Mittnacht J; Schulze E; Alrajab A; Grulich-Henn J; Bettendorf M
J Pediatr Endocrinol Metab; 2019 Mar; 32(3):259-267. PubMed ID: 30817301
[TBL] [Abstract][Full Text] [Related]
11. Zona fasciculata 21-hydroxysteroids and precursor-to-product ratios in 21-hydroxylase deficiency: further characterization of classic and non-classic patients and heterozygote carriers.
Costa-Barbosa FA; Carvalho VM; Nakamura OH; Bachega TA; Vieira JG; Kater CE
J Endocrinol Invest; 2011 Sep; 34(8):587-92. PubMed ID: 20924223
[TBL] [Abstract][Full Text] [Related]
12. A diagnosis not to be missed: nonclassic steroid 11β-hydroxylase deficiency presenting with premature adrenarche and hirsutism.
Reisch N; Högler W; Parajes S; Rose IT; Dhir V; Götzinger J; Arlt W; Krone N
J Clin Endocrinol Metab; 2013 Oct; 98(10):E1620-5. PubMed ID: 23940125
[TBL] [Abstract][Full Text] [Related]
13. Congenital Adrenal Hyperplasia: Time to Replace 17OHP with 21-Deoxycortisol.
Miller WL
Horm Res Paediatr; 2019; 91(6):416-420. PubMed ID: 31450227
[TBL] [Abstract][Full Text] [Related]
14. Profiles of 21-Carbon Steroids in 21-hydroxylase Deficiency.
Turcu AF; Rege J; Chomic R; Liu J; Nishimoto HK; Else T; Moraitis AG; Palapattu GS; Rainey WE; Auchus RJ
J Clin Endocrinol Metab; 2015 Jun; 100(6):2283-90. PubMed ID: 25850025
[TBL] [Abstract][Full Text] [Related]
15. Case Report: A Novel Mutation Leading to 11-β Hydroxylase Deficiency in a Female Patient.
Ozbas B; Demir M; Dursun H; Sahin I; Hacioglu A; Karaca Z; Dundar M; Unluhizarci K
Endocr Metab Immune Disord Drug Targets; 2023; 23(5):721-726. PubMed ID: 36214299
[TBL] [Abstract][Full Text] [Related]
16. Congenital adrenal hyperplasia: 11beta-hydroxylase deficiency.
Peter M
Semin Reprod Med; 2002 Aug; 20(3):249-54. PubMed ID: 12428205
[TBL] [Abstract][Full Text] [Related]
17. Late diagnosis of congenital adrenal hyperplasia due to 21-hydroxylase deficiency.
Müssig K; Kaltenbach S; Maser-Gluth C; Hartmann MF; Wudy SA; Horger M; Gallwitz B; Raue F; Häring HU; Schulze E
Exp Clin Endocrinol Diabetes; 2006 Apr; 114(4):208-14. PubMed ID: 16705555
[TBL] [Abstract][Full Text] [Related]
18. 3 alpha-androstanediol glucuronide in virilizing congenital adrenal hyperplasia: a useful serum metabolic marker of integrated adrenal androgen secretion.
Pang S; MacGillivray M; Wang M; Jeffries S; Clark A; Rosenthal I; Wiegensberg M; Riddick L
J Clin Endocrinol Metab; 1991 Jul; 73(1):166-74. PubMed ID: 2045467
[TBL] [Abstract][Full Text] [Related]
19. Clinical perspectives in congenital adrenal hyperplasia due to 11β-hydroxylase deficiency.
Bulsari K; Falhammar H
Endocrine; 2017 Jan; 55(1):19-36. PubMed ID: 27928728
[TBL] [Abstract][Full Text] [Related]
20. LC-MS/MS based determination of basal- and ACTH-stimulated plasma concentrations of 11 steroid hormones: implications for detecting heterozygote CYP21A2 mutation carriers.
Kulle AE; Riepe FG; Hedderich J; Sippell WG; Schmitz J; Niermeyer L; Holterhus PM
Eur J Endocrinol; 2015 Oct; 173(4):517-24. PubMed ID: 26315375
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
